LH708
LH708 is an orally active L-cystine crystallization inhibitor with an EC50 of 59.8 nM. LH708 can be used for Cystinuria research[1].
Product Specifications
CAS Number
1616757-93-7
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/lh708.html
Solubility
10 mM in DMSO
Smiles
CN1CCN(C([C@@H](N)CSSC[C@H](N)C(N2CCN(C)CC2)=O)=O)CC1.Cl.Cl.Cl.Cl
Molecular Formula
C16H36Cl4N6O2S2
Molecular Weight
550.44
References & Citations
[1]Longqin Hu, et al. 8-l-Cystinyl Bis (1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for Cystinuria, ACS Medicinal Chemistry Letters, Article ASAP
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042610-500 1x 500 µL
ZNF690 / ZSCAN29 (ZSCAN29/2610), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB0940-500 1x 500 µL
Glucose Regulated Protein 94 (GRP94) (9G10.F8.2), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details